天士力斩获第十四届金融界“金智奖”医药生物产业优胜奖， 双引擎创新驱动高质量发展

Core Insights - The "Qihang·2025 Financial Summit" was successfully held in Beijing, focusing on "New Starting Point, New Momentum, New Journey," gathering leaders and guests from various sectors including regulatory bodies, industry associations, financial institutions, and media [1] - The 14th "Golden Wisdom Award" results were announced, with Tianshili winning the "Excellence Award in the Pharmaceutical and Biological Industry" [2] Group 1: Award Significance - The "Golden Wisdom Award" aims to establish benchmarks for high-quality development, guiding listed companies to focus on their core businesses, innovate continuously, and fulfill social responsibilities [3] - The award reflects the industry's recognition of Tianshili's core competitiveness and high-quality development achievements, emphasizing its commitment to innovation and industry leadership [4] Group 2: Financial Performance - In the first three quarters of 2025, Tianshili achieved pharmaceutical industrial revenue of 5.709 billion yuan, maintaining a steady growth trend [4] - The net profit attributable to shareholders reached 984 million yuan, representing a year-on-year increase of 16.88%, indicating a steady improvement in profitability [4] Group 3: Innovation and R&D - Tianshili's innovation is a core driver of its high-quality development, with a dual-engine R&D system for innovative traditional Chinese medicine and biopharmaceuticals now entering a phase of significant results [4] - The company has 31 innovative drugs in its pipeline, with nearly 20 traditional Chinese medicines in late clinical stages, showcasing its long-term innovation potential [5] Group 4: Future Outlook - The award signifies industry confidence in Tianshili's "dual-engine" innovation strategy and future growth prospects [6] - Tianshili plans to deepen its investment in innovation, accelerate the conversion of pipeline results, and optimize its core business layout to contribute to public health and the upgrade of the biopharmaceutical industry [6]